Reuters logo
BRIEF-Five Prime Therapeutics Q2 loss per share $1.58
2017年8月8日 / 晚上8点12分 / 1 个月前

BRIEF-Five Prime Therapeutics Q2 loss per share $1.58

Aug 8 (Reuters) - Five Prime Therapeutics Inc

* Five Prime announces second quarter 2017 results and provides business update

* Q2 loss per share $1.58

* Q2 earnings per share view $-1.21 -- Thomson Reuters I/B/E/S

* Five Prime Therapeutics - ‍cash, cash equivalents and marketable securities totaled $350.7 million on June 30, 2017, compared to $421.7 million on Dec 31, 2016​

* Five Prime Therapeutics Inc - ‍collaboration revenue for Q2 of 2017 decreased by $1.4 million to $7.8 million from $9.2 million in Q2 of 2016​

* Five Prime Therapeutics Inc - expects full-year 2017 net cash used in operating activities to be less than $120 million​

* Five Prime Therapeutics Inc - ‍estimates ending 2017 with slightly less than $300 million in cash, cash equivalents and marketable securities​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below